Source: Oncology  |  Posted 8 years ago

Docetaxel combined with cisplatin with or without human granulocyte colony stimulating factor (G-CSF) and/or erythropoietin appears to show a promising therapeutic index in patients with advanced gastroesophageal cancer.

Cytotoxic chemotherapy has been demonstrated to be effective in the palliative management of gastroesophageal cancer. However, use of chemotherapy in patients with disseminated disease is aimed at producing palliative effects, and the anticancer activity and side effects must be weighted carefully.

Birgit Sch